OPS
REGN icon

Orion Portfolio Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

Orion Portfolio Solutions’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.16M Sell
1,830
-252
-12% -$173K 0.01% 1002
2024
Q4 		$1.48M Sell
2,082
-489
-19% -$410K 0.01% 842
2024
Q3 		$2.7M Sell
2,571
-302
-11% -$336K 0.03% 542
2024
Q2 		$3.02M Buy
2,873
+138
+5% +$134K 0.03% 473
2024
Q1 		$2.63M Sell
2,735
-36
-1% -$34.2K 0.03% 528
2023
Q4 		$2.5M Sell
2,771
-12,934
-82% -$10.7M 0.03% 534
2023
Q3 		$12.9M Sell
15,705
-1,109
-7% -$872K 0.16% 138
2023
Q2 		$12.1M Sell
16,814
-458
-3% -$353K 0.13% 153
2023
Q1 		$14.2M Buy
17,272
+15,715
+1,009% +$11.9M 0.18% 122
2022
Q4 		$1.12M Buy
1,557
+168
+12% +$124K 0.04% 279
2022
Q3 		$957K Buy
1,389
+310
+29% +$195K 0.04% 276
2022
Q2 		$638K Buy
1,079
+117
+12% +$76.1K 0.03% 345
2022
Q1 		$672K Buy
962
+20
+2% +$12.7K 0.02% 352
2021
Q4 		$595K Sell
942
-381
-29% -$234K 0.02% 383
2021
Q3 		$801K Buy
1,323
+747
+130% +$464K 0.03% 293
2021
Q2 		$322K Buy
576
+2
+0.3% +$1.01K 0.01% 470
2021
Q1 		$272K Sell
574
-2,518
-81% -$1.23M 0.01% 461
2020
Q4 		$1.49M Buy
3,092
+1,010
+49% +$545K 0.07% 155
2020
Q3 		$1.17M Buy
2,082
+1,770
+567% +$1.07M 0.06% 170
2020
Q2 		$195K Buy
312
+122
+64% +$69.2K 0.01% 413
2020
Q1 		$93K Buy
190
+33
+21% +$13.6K 0.01% 459
2019
Q4 		$59K Buy
+157
New +$52.8K ﹤0.01% 523

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Orion Portfolio Solutions's REGN Position: Q1 2025 in Review

Orion Portfolio Solutions reduced its Regeneron Pharmaceuticals (REGN) stake by 12% in Q1 2025, selling an estimated $173K and leaving 1,830 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #1002.

Orion Portfolio Solutions first reported a position in REGN in Q4 2019 and has held it in 22 quarters since. The position peaked at $14.2M in Q1 2023. 1,290 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • Orion Portfolio Solutions held 1,830 shares of Regeneron Pharmaceuticals worth $1.16M as of Q1 2025.
  • Orion Portfolio Solutions sold 252 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $173K.
  • Regeneron Pharmaceuticals made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1002 holding.
  • Orion Portfolio Solutions first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 22 quarters since.
  • Orion Portfolio Solutions's Regeneron Pharmaceuticals position peaked at $14.2M in Q1 2023.
  • 1,290 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.